New edition of WHO prequalification list to include four new anti-AIDS medicines

Four new AIDS medicines are this week being added to the World Health Organization (WHO) prequalification list, thus further increasing access to a choice of quality products. At the same time, product assessment reports on quality and bioequivalence of triple fixed-dose combination (FDCs) antiretrovirals already prequalified will be made public. Manufacturing site inspection findings will soon also be published, which will make the WHO prequalification the most transparent of all similar quality assurance programmes to date.

Do NOT follow this link or you will be banned from the site!